ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Datametrex Launches Beta Medi-Call In-Person Patient Care

By: Newsfile

Toronto, Ontario--(Newsfile Corp. - November 1, 2021) - Datametrex AI Limited (TSXV: DM) (FSE: D4G) (OTCQB: DTMXF) (the "Company" or "Datametrex") is pleased to announce that its wholly-owned subsidiary Medi-Call MD Inc, ("Medi-Call") is officially launching expanded Medi-Call services to include in-person visits at a residential or work setting in Greater Vancouver Area (GVA).

The Company has been working with the development team to create an ecosystem where certified physicians can not only examine patients via its mobile app but also can be dispatched to patients' residences or places of work to provide medical services in person. Patients would be able to make the appointment through the Medi-Call app and go on with their daily business until the physician arrives. Patients can track the progress of the doctor and wait for their expected visit in real-time on the Medi-Call app with its alert system.

"We are excited to announce the addition of a crucial service for Medi-Call subscribers. A physical visit by a physician has been proven optimal for efficacious diagnostic and treatment results, as not all primary care level visits can be dealt with safely and efficiently via video or telehealth. In-person Medi-Call visits in addition to e-health improve the patients' experience by increasing access to care and healthcare delivery at large," stated Dr. Omar Sharif, President of Medi-Call and Chief Medical Officer of Datamertrex.

"Medi-Call is committed to preserving ongoing continuity of care and the highest clinical standards. Patients will have the option of requesting their favourite providers, but if time is of critical importance on a given day, the nearest provider even if different, will have full access to all their medical history through the safe and secure electronic medical record-keeping system. Regardless of visit location even if it is in a different city. So, in essence, a patient's doctor's office will for the first time, travel with the client throughout Canada," said Marshall Gunter, CEO of the Company.

About Medi-Call MD Inc.

Medi-Call is an enhanced telemedicine company providing technology-driven e-health or m-health care services including prescriptions, launching initially in British Columbia, and then expanding across Canada. The objectives of Medi-Call, include making health care accessible to people who live in rural or isolated communities and making services more readily available or convenient for people with limited time, mobility, or transportation choices. Medi-Call is driven to improve coordination and communication of treatment among members of a health care team and its patients.

About Datametrex

Datametrex AI Limited is a technology-focused company with exposure to Artificial Intelligence and Machine Learning through its wholly-owned subsidiary, Nexalogy (www.nexalogy.com). Datametrex's mission is to provide tools that support companies in fulfilling their operational goals, including Health and Safety, with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, Company provides progressive solutions to support the supply chain.

For additional information on Datametrex and other corporate information, please visit the Company's website at www.datametrex.com.

For further information, please contact:
Marshall Gunter - CEO
Phone: (514) 295-2300
Email: mgunter@datametrex.com

Neither the TSX Venture Exchange nor it's Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements:

All statements included in this press release that address activities, events, or developments that the Company expects, believes, or anticipates will or may occur in the future are forward-looking statements. These forward-looking statements involve numerous assumptions made by the Company based on its experience, perception of historical trends, current conditions, expected future developments and other factors it believes are appropriate in the circumstances. In addition, these statements involve substantial known and unknown risks and uncertainties that contribute to the possibility that the predictions, forecasts, projections, and other forward-looking statements will prove inaccurate, certain of which are beyond the Company's control. In particular, there is no guarantee that the parties will successfully negotiate and enter into a definitive agreement on mutually acceptable terms or complete the Transaction in the manner contemplated herein, if at all, that the due diligence of any of the parties will be satisfactory, or that the parties will obtain any required board, shareholder, third-party and/or regulatory or other governmental approvals, if any. Readers should not place undue reliance on forward-looking statements. Except as required by law, the Company does not undertake to revise or update these forward-looking statements after the date hereof or revise them to reflect the occurrence of future unanticipated events.

###

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/101201

Recent Quotes

View More
Symbol Price Change (%)
AMZN  227.78
-1.75 (-0.76%)
AAPL  277.39
-1.39 (-0.50%)
AMD  218.91
+0.94 (0.43%)
BAC  53.92
-0.03 (-0.06%)
GOOG  316.50
-5.59 (-1.74%)
META  669.46
-3.96 (-0.59%)
MSFT  491.09
+7.93 (1.64%)
NVDA  183.46
+1.05 (0.58%)
ORCL  218.73
+1.15 (0.53%)
TSLA  438.55
-16.45 (-3.62%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.